Emerging research highlights the underexplored role of gut neuropeptides in Parkinson’s disease, revealing new connections ...

Researchers at Karolinska Institutet in Stockholm, Sweden, have shown that specific blood biomarkers can predict development of dementia up to 10 years before symptoms appear. But their primary value ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

A UF study finds that two common diabetes drugs may help protect against Alzheimer’s disease in older adults with Type 2 ...

Menopause and the natural phenomenon of weight gain in middle age make this a topic for primary care physicians to watch.

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Two popular glucose-lowering drugs may protect against Alzheimer's disease and related dementias in patients with type 2 ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...